248 related articles for article (PubMed ID: 9288794)
1. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells.
Fulda S; Sieverts H; Friesen C; Herr I; Debatin KM
Cancer Res; 1997 Sep; 57(17):3823-9. PubMed ID: 9288794
[TBL] [Abstract][Full Text] [Related]
2. Activation of the CD95 (APO-1/Fas) pathway in drug- and gamma-irradiation-induced apoptosis of brain tumor cells.
Fulda S; Scaffidi C; Pietsch T; Krammer PH; Peter ME; Debatin KM
Cell Death Differ; 1998 Oct; 5(10):884-93. PubMed ID: 10203687
[TBL] [Abstract][Full Text] [Related]
3. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
[TBL] [Abstract][Full Text] [Related]
4. Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma.
Glick RD; Swendeman SL; Coffey DC; Rifkind RA; Marks PA; Richon VM; La Quaglia MP
Cancer Res; 1999 Sep; 59(17):4392-9. PubMed ID: 10485488
[TBL] [Abstract][Full Text] [Related]
5. Molecular determinants of apoptosis induced by cytotoxic drugs.
Fulda S; Friesen C; Debatin KM
Klin Padiatr; 1998; 210(4):148-52. PubMed ID: 9743944
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced apoptosis in osteosarcoma cell lines is mediated by caspase activation independent of CD95-receptor/ligand interaction.
Fellenberg J; Mau H; Nedel S; Ewerbeck V; Debatin KM
J Orthop Res; 2000 Jan; 18(1):10-7. PubMed ID: 10716273
[TBL] [Abstract][Full Text] [Related]
7. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
Spierings DC; de Vries EG; Vellenga E; de Jong S
Cell Death Differ; 2003 Jul; 10(7):808-22. PubMed ID: 12815464
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells.
Villunger A; Egle A; Kos M; Hartmann BL; Geley S; Kofler R; Greil R
Cancer Res; 1997 Aug; 57(16):3331-4. PubMed ID: 9269989
[TBL] [Abstract][Full Text] [Related]
9. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
10. p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells.
Ruiz-Ruiz MC; López-Rivas A
Cell Death Differ; 1999 Mar; 6(3):271-80. PubMed ID: 10200578
[TBL] [Abstract][Full Text] [Related]
11. Induction of CD95 ligand and apoptosis by doxorubicin is modulated by the redox state in chemosensitive- and drug-resistant tumor cells.
Friesen C; Fulda S; Debatin KM
Cell Death Differ; 1999 May; 6(5):471-80. PubMed ID: 10381639
[TBL] [Abstract][Full Text] [Related]
12. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
[TBL] [Abstract][Full Text] [Related]
13. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2.
Dirsch VM; Stuppner H; Vollmar AM
Cancer Res; 2001 Aug; 61(15):5817-23. PubMed ID: 11479221
[TBL] [Abstract][Full Text] [Related]
14. A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells.
Juang SH; Pan WY; Kuo CC; Liou JP; Hung YM; Chen LT; Hsieh HP; Chang JY
Biochem Pharmacol; 2004 Jul; 68(2):293-303. PubMed ID: 15194001
[TBL] [Abstract][Full Text] [Related]
15. Caspase-1 is not involved in CD95/Fas-induced apoptosis in Jurkat T cells.
Chow SC; Slee EA; MacFarlane M; Cohen GM
Exp Cell Res; 1999 Feb; 246(2):491-500. PubMed ID: 9925765
[TBL] [Abstract][Full Text] [Related]
16. Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-L-phenylalanylchloromethyl ketone-sensitive activities.
Sané AT; Bertrand R
Cancer Res; 1998 Jul; 58(14):3066-72. PubMed ID: 9679972
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells.
Milner AE; Palmer DH; Hodgkin EA; Eliopoulos AG; Knox PG; Poole CJ; Kerr DJ; Young LS
Cell Death Differ; 2002 Mar; 9(3):287-300. PubMed ID: 11859411
[TBL] [Abstract][Full Text] [Related]
18. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors.
Fulda S; Friesen C; Los M; Scaffidi C; Mier W; Benedict M; Nuñez G; Krammer PH; Peter ME; Debatin KM
Cancer Res; 1997 Nov; 57(21):4956-64. PubMed ID: 9354463
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of FLIP in cisplatin-selected HeLa cells causes cross-resistance to CD95/Fas death signalling.
Kamarajan P; Sun NK; Chao CC
Biochem J; 2003 Nov; 376(Pt 1):253-60. PubMed ID: 12911332
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.
Mitsiades N; Yu WH; Poulaki V; Tsokos M; Stamenkovic I
Cancer Res; 2001 Jan; 61(2):577-81. PubMed ID: 11212252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
